Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 18

1.

Pouchitis in pediatric ulcerative colitis: A multicenter study on behalf of Italian Society of Pediatric Gastroenterology, Hepatology and Nutrition.

Dipasquale V, Mattioli G, Arrigo S, Bramuzzo M, Strisciuglio C, Faraci S, Romeo EF, Contini AC, Ventimiglia M, Zuin G, Felici E, Alvisi P, Romano C.

Dig Liver Dis. 2019 Nov;51(11):1551-1556. doi: 10.1016/j.dld.2019.06.023. Epub 2019 Jul 16.

PMID:
31324473
2.

Efficacy and safety of infliximab in very early onset inflammatory bowel disease: a national comparative retrospective study.

Bramuzzo M, Arrigo S, Romano C, Filardi MC, Lionetti P, Agrusti A, Dipasquale V, Paci M, Zuin G, Aloi M, Strisciuglio C, Miele E, Pastore M, Martelossi S, Alvisi P; SIGENP IBD Working Group.

United European Gastroenterol J. 2019 Jul;7(6):759-766. doi: 10.1177/2050640619847592. Epub 2019 Apr 25.

3.

Efficacy of adalimumab as second-line therapy in a pediatric cohort of Crohn's disease patients who failed infliximab therapy: the Italian Society of Pediatric Gastroenterology, Hepatology, and Nutrition experience.

Alvisi P, Arrigo S, Cucchiara S, Lionetti P, Miele E, Romano C, Ravelli A, Knafelz D, Martelossi S, Guariso G, Accomando S, Zuin G, De Giacomo C, Balzani L, Gennari M, Aloi M; SIGENP IBD Working Group.

Biologics. 2019 Jan 3;13:13-21. doi: 10.2147/BTT.S183088. eCollection 2019.

4.

Italian pediatric nutrition survey.

Lezo A, Diamanti A, Capriati T, Gandullia P, Fiore P, Lacitignola L, Gatti S, Spagnuolo MI, Cecchi N, Verlato G, Borodani S, Forchielli L, Panceri R, Brunori E, Pastore M, Amarri S; SIGENP Nutrition Day Group.

Clin Nutr ESPEN. 2017 Oct;21:72-78. doi: 10.1016/j.clnesp.2017.05.002. Epub 2017 Aug 21.

PMID:
30014872
5.

Efficacy and Safety of Adalimumab in Pediatric Ulcerative Colitis: A Real-life Experience from the SIGENP-IBD Registry.

Aloi M, Bramuzzo M, Arrigo S, Romano C, D'Arcangelo G, Lacorte D, Gatti S, Illiceto MT, Zucconi F, Dilillo D, Zuin G, Knafelz D, Ravelli A, Cucchiara S, Alvisi P; SIGENP IBD Working Group.

J Pediatr Gastroenterol Nutr. 2018 Jun;66(6):920-925. doi: 10.1097/MPG.0000000000001883.

PMID:
29315163
6.

Risk Factors and Outcomes of Thalidomide-induced Peripheral Neuropathy in a Pediatric Inflammatory Bowel Disease Cohort.

Bramuzzo M, Stocco G, Montico M, Arrigo S, Calvi A, Lanteri P, Costa S, Pellegrino S, Magazzù G, Barp J, Ghione S, Lionetti P, Zuin G, Fontana M, Di Chio T, Maggiore G, Lazzerini M, Lucafò M, Udina C, Pellegrin MC, Chicco A, Carrozzi M, Decorti G, Ventura A, Martelossi S.

Inflamm Bowel Dis. 2017 Oct;23(10):1810-1816. doi: 10.1097/MIB.0000000000001195.

PMID:
28817461
7.

Colonic inflammation in pediatric inflammatory bowel disease: detection with magnetic resonance enterography.

Campari A, Napolitano M, Zuin G, Maestri L, Di Leo G, Sardanelli F.

Pediatr Radiol. 2017 Jun;47(7):850-859. doi: 10.1007/s00247-017-3833-x. Epub 2017 Apr 17.

PMID:
28417181
8.

Endoscopic and Histologic Healing in Children With Inflammatory Bowel Diseases Treated With Thalidomide.

Lazzerini M, Villanacci V, Pellegrin MC, Martelossi S, Magazzù G, Pellegrino S, Lucanto MC, Barabino A, Calvi A, Arrigo S, Lionetti P, Fontana M, Zuin G, Maggiore G, Bramuzzo M, Maschio M, Salemme M, Manenti S, Lorenzi L, Decorti G, Montico M, Ventura A.

Clin Gastroenterol Hepatol. 2017 Sep;15(9):1382-1389.e1. doi: 10.1016/j.cgh.2017.02.029. Epub 2017 Mar 7.

PMID:
28286192
9.

Nutrition in Pediatric Inflammatory Bowel Disease: From Etiology to Treatment. A Systematic Review.

Penagini F, Dilillo D, Borsani B, Cococcioni L, Galli E, Bedogni G, Zuin G, Zuccotti GV.

Nutrients. 2016 Jun 1;8(6). pii: E334. doi: 10.3390/nu8060334. Review.

10.

Clinical Features and Risk Factors of Autoimmune Liver Involvement in Pediatric Inflammatory Bowel Disease.

Bramuzzo M, Martelossi S, Torre G, Cardile S, Arrigo S, Vignola S, Ferrari F, Zuin G, Illiceto MT, Gasparetto M, Pellegrino S, Romano C, Maggiore G, Montico M, Aloi M; SIGENP IBD Group.

J Pediatr Gastroenterol Nutr. 2016 Aug;63(2):259-64. doi: 10.1097/MPG.0000000000001078.

PMID:
26756875
11.

Effect of Thalidomide on Clinical Remission in Children and Adolescents with Ulcerative Colitis Refractory to Other Immunosuppressives: Pilot Randomized Clinical Trial.

Lazzerini M, Martelossi S, Magazzù G, Pellegrino S, Lucanto MC, Barabino A, Calvi A, Arrigo S, Lionetti P, Lorusso M, Mangiantini F, Fontana M, Zuin G, Palla G, Maggiore G, Bramuzzo M, Pellegrin MC, Maschio M, Villanacci V, Manenti S, Decorti G, De Iudicibus S, Paparazzo R, Montico M, Ventura A.

Inflamm Bowel Dis. 2015 Aug;21(8):1739-49. doi: 10.1097/MIB.0000000000000437.

PMID:
26185909
12.

Orofacial granulomatosis in children: think about Crohn's disease.

Lazzerini M, Martelossi S, Cont G, Bersanini C, Ventura G, Fontana M, Zuin G, Ventura A, Taddio A.

Dig Liver Dis. 2015 Apr;47(4):338-41. doi: 10.1016/j.dld.2014.12.012. Epub 2014 Dec 30.

PMID:
25618553
13.

Introduction of gluten, HLA status, and the risk of celiac disease in children.

Lionetti E, Castellaneta S, Francavilla R, Pulvirenti A, Tonutti E, Amarri S, Barbato M, Barbera C, Barera G, Bellantoni A, Castellano E, Guariso G, Limongelli MG, Pellegrino S, Polloni C, Ughi C, Zuin G, Fasano A, Catassi C; SIGENP (Italian Society of Pediatric Gastroenterology, Hepatology, and Nutrition) Working Group on Weaning and CD Risk.

N Engl J Med. 2014 Oct 2;371(14):1295-303. doi: 10.1056/NEJMoa1400697.

14.

Effect of thalidomide on clinical remission in children and adolescents with refractory Crohn disease: a randomized clinical trial.

Lazzerini M, Martelossi S, Magazzù G, Pellegrino S, Lucanto MC, Barabino A, Calvi A, Arrigo S, Lionetti P, Lorusso M, Mangiantini F, Fontana M, Zuin G, Palla G, Maggiore G, Bramuzzo M, Pellegrin MC, Maschio M, Villanacci V, Manenti S, Decorti G, De Iudicibus S, Paparazzo R, Montico M, Ventura A.

JAMA. 2013 Nov 27;310(20):2164-73. doi: 10.1001/jama.2013.280777.

PMID:
24281461
15.

Prevalence and natural history of potential celiac disease in at-family-risk infants prospectively investigated from birth.

Lionetti E, Castellaneta S, Pulvirenti A, Tonutti E, Francavilla R, Fasano A, Catassi C; Italian Working Group of Weaning and Celiac Disease Risk.

J Pediatr. 2012 Nov;161(5):908-14. doi: 10.1016/j.jpeds.2012.05.008. Epub 2012 Jun 15.

PMID:
22704250
16.

Family history of irritable bowel syndrome is the major determinant of persistent abdominal complaints in young adults with a history of pediatric recurrent abdominal pain.

Pace F, Zuin G, Di Giacomo S, Molteni P, Casini V, Fontana M, Porro GB.

World J Gastroenterol. 2006 Jun 28;12(24):3874-7.

17.

Clinical features and progression of perinatally acquired hepatitis C virus infection.

Resti M, Jara P, Hierro L, Azzari C, Giacchino R, Zuin G, Zancan L, Pedditzi S, Bortolotti F.

J Med Virol. 2003 Jul;70(3):373-7.

PMID:
12766999
18.

Maternal drug use is a preeminent risk factor for mother-to-child hepatitis C virus transmission: results from a multicenter study of 1372 mother-infant pairs.

Resti M, Azzari C, Galli L, Zuin G, Giacchino R, Bortolotti F, Marcellini M, Moriondo M, de Martino M, Vierucci A; Italian Study Group on Mother-to-Infant Hepatitis C Virus Transmission.

J Infect Dis. 2002 Mar 1;185(5):567-72. Epub 2002 Feb 14.

PMID:
11865412

Supplemental Content

Loading ...
Support Center